Renal Denervation Insights
Published: 12 February 2021
Part 2 | Session 1 The Science of Radiofrequency Renal Denervation – Part 1
Part 2 | Session 2 The Science of Radiofrequency Renal Denervation – Part 2
Part 2 | Session 3 TCT 2019: RF renal denervation – Prof Andrew Sharp
Part 1 | Session 1 The Future of Hypertension Management – Renal Denervation Provides Another Treatment Option Justin E Davies, Faisal Sharif, Roland E Schmieder, Flavio Ribichini, Isabella Sudano
Part 1 | Session 2 El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento Oriol Rodriguez, Maribel Troya
Global Experts Discuss Renal Denervation as an Additional Treatment Option for Uncontrolled Hypertension
Review the evidence on radiofrequency renal denervation, including safety, efficacy and durability data and practical aspects around patient selection and management.
Medical Education Program
Patient Selection and Practical Implementation of Renal Denervation in Patients With Treatment-Resistant Hypertension
This case-based course brings together opinion leaders engaged in RDN to review the evidence, discuss trial data, and practical aspects around patient selection and management.
Click here to watch:
More from this programme
Clinical Data and Patient Identification
Science of Radiofrequency Renal Denervation
Prof Flavio Ribichini is a board certificated Cardiologist at the University of Turin, the Director of the School of Cardiovascular Diseases of the School of Medicine University of Verona, and Clinical Director of the Division of Cardiology of AOUI, Verona.
Prof Ribichini is an interventionalist dedicated to vascular angioplaties, valvular replacement and congenital intervention.
Professor Stefano Taddei works at the Department of Medicine at the University of Pisa, Italy. He currently serves as a Fellow of the European Society of Cardiology, the European Society of Hypertension, and the International Society of Hypertension.